As you all are aware of this year, we have published a lot of brilliant reviews on some of the hottest topics in the Biotech Industry! This article highlights our favourite ones for 2015! Click the titles to read more…


DNA_CRSIPR-Cas9_Therapeutics

 Review: The CRISPR’s Therapeutical revolution

CRISPR has an enormous potential in therapeutic development and many Biotech and Big Pharma companies are already researching into the area. This review explains what CRISPR actually is, the mechanisms behind it and how it could be utilized for therapeutics.

ADVERTISEMENT


microbiome_seres_eligo_flagship_cancer_evelo

Colourful Microbiota (Graphics Source: Eligo Biosciences)

What will Happen now the Microbiome Hype has Broken into the Immuno-Oncology Field?

The microbial cells inhabiting our body make up what is called the “microbiome” and this field is very new in Biotech. Recently, evidence has been presented that suggests immunotherapy is reliant on this gut microflora. This review goes into depth on what microbiome companies are doing in the immuno-oncology area.


CC BrightMags

The Ultimate Review on how Biotech Changed Cancer Treatment

The Biotech Industry has and will continue to play a major role in the treatment of cancers. This review goes into greater detail of these treatments, including monoclonal antibodies, gene therapy and CAR-T. It goes on to explain what is next between Biotech and oncology.


Alzheimer's

Background (Source: National Institute on Aging), Brain Graphic (CC: Allan Ajifo @ aboutmodafinil.com)

What Exciting Developments Have Been Made in Neurodegenerative Disease this Year?

Alzheimer’s and Parkinson’s affects 50 million people worldwide and the biotech industry is a major player in researching treatment for these diseases. This review gives a brief summary on a selection of neurodegenerative diseases and the research that is being put into them.


blue_ocean_rare_disease_biotech

Rare Diseases: Still a ‘Blue Ocean’ for Biotechs?

Rare diseases are a major focus of many Biotech companies for a number of reasons. This review looks deeper into some of these companies to find out why they are looking into these rare diseases and understand the changes happening.


CAR-T (Credit: Cellectis)

CAR-T (Credit: Cellectis)

Ultimate Review: CAR-T is The Game-changer in Cancer Treatments

CAR-T has been arguably the hottest topic of 2015 within the oncology field of Biotech. This review explains what this specific Cell Therapy actually is, how it can be turned into a product and the front runners of CAR-T race. We definitely have not seen the end of this game-changing cell.


We hope you have enjoyed all of our reviews in 2015 and don’t worry, we will continue to provide awesome content for you in the new year and throughout 2016!

Previous post

Got a Smartphone for Christmas? Download our app now!

Next post

The 3 Worst Biotech Scandals of 2015!

Let's Continue The Conversation

Feel free to send us comments about this article to comments@labiotech.eu and/or comment on that article on social media.